Production of TNFα and IL-6 by Activated Whole Blood from HIV-1 Infected Patients Detected by a One-Stage Procedure: Relationship with the Phenotype of HIV-1 Isolates

Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL-6 production using small volumes of WB (25μl) from HIV-1 positive patients with a one-step procedure that combines WB stimulation with LPS, PHA and cytokine mea...

Full description

Saved in:
Bibliographic Details
Published inMICROBIOLOGY and IMMUNOLOGY Vol. 41; no. 12; pp. 939 - 946
Main Authors Benyoucef, Samira, Hober, Didier, Shen, Lu, Ajana, Faïza, De Groote, Donat, Bocket-Mouton, Laurence, Gérard, Yann, Lion, Georges, Vilain, Virginie, Wattré, Pierre
Format Journal Article
LanguageEnglish
Published Tokyo Blackwell Publishing Ltd 01.01.1997
Center For Academic Publications Japan
Center for Academic Publications Japan
Subjects
Online AccessGet full text
ISSN0385-5600
1348-0421
DOI10.1111/j.1348-0421.1997.tb01953.x

Cover

Loading…
Abstract Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL-6 production using small volumes of WB (25μl) from HIV-1 positive patients with a one-step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNFα and IL-6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNFα than the mean+2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNFα values were lower than the mean -2 S.D. of the control group. Low IL-6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNFα production in vitro and plasma level of TNFα. We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T-cell count in peripheral blood. Our data point out a disarray in TNFα and IL-6 production by WB from HIV-1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV-1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNFα produced by WB and the phenotype of HIV-1 isolates isolated from patients. The one-stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV-1 positive individuals and predicting HIV-1 phenotype.
AbstractList Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNF alpha and IL-6 production using small volumes of WB (25 mu l) from HIV-1 positive patients with a one-step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNF alpha and IL-6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNF alpha than the mean + 2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNF alpha values were lower than the mean - 2 S.D. of the control group. Low IL-6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNF alpha production in vitro and plasma level of TNF alpha . We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T-cell count in peripheral blood. Our data point out a disarray in TNF alpha and IL-6 production by WB from HIV-1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV-1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNF alpha produced by WB and the phenotype of HIV-1 isolates isolated from patients. The one-stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV-1 positive individuals and predicting HIV-1 phenotype.
Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL-6 production using small volumes of WB (25μl) from HIV-1 positive patients with a one-step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNFα and IL-6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNFα than the mean+2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNFα values were lower than the mean -2 S.D. of the control group. Low IL-6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNFα production in vitro and plasma level of TNFα. We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T-cell count in peripheral blood. Our data point out a disarray in TNFα and IL-6 production by WB from HIV-1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV-1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNFα produced by WB and the phenotype of HIV-1 isolates isolated from patients. The one-stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV-1 positive individuals and predicting HIV-1 phenotype.
Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL‐6 production using small volumes of WB (25 μl) from HIV‐1 positive patients with a one‐step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNFα and IL‐6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNFα than the mean + 2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNFα values were lower than the mean −2 S.D. of the control group. Low IL‐6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNFα production in vitro and plasma level of TNFα. We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T‐cell count in peripheral blood. Our data point out a disarray in TNFα and IL‐6 production by WB from HIV‐1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV‐1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNFα produced by WB and the phenotype of HIV‐1 isolates isolated from patients. The one‐stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV‐1 positive individuals and predicting HIV‐1 phenotype.
Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL‐6 production using small volumes of WB (25 μl) from HIV‐1 positive patients with a one‐step procedure that combines WB stimulation with LPS, PHA and cytokine measurement. We studied 49 patients without secondary infection or at distance of secondary infection staged according to the 1993 classification of the CDC and 12 healthy seronegative subjects. Heparinized blood from 5 control subjects had been collected sequentially during a period of 5 months. The individual variations of TNFα and IL‐6 production were limited for all these individuals. In 1 out of 20 CDC group A patients, 6 out of 17 CDC group B patients and 3 out of 12 CDC group C patients, we obtained higher values of TNFα than the mean + 2 S.D. of the control group. In 3 out of 20 CDC group A patients, 1 out of 17 CDC group B patients without AIDS and 5 out of 12 CDC group C patients, the TNFα values were lower than the mean −2 S.D. of the control group. Low IL‐6 values were obtained in 1 out of 20 CDC group A patients and 1 out of 17 CDC group B patients and 3 out of 12 CDC group C patients. There was no correlation between TNFα production in vitro and plasma level of TNFα. We found no correlation between the levels of cytokines and monocyte count or between the levels of cytokines and CD4 T‐cell count in peripheral blood. Our data point out a disarray in TNFα and IL‐6 production by WB from HIV‐1 infected patients. The relationship between the disarray of cytokine production and cytopathogenicity of HIV‐1 isolates in the P4 cell line was investigated in this study. We found a correlation between the high level of TNFα produced by WB and the phenotype of HIV‐1 isolates isolated from patients. The one‐stage procedure used in this work is of potential value to investigate the activation status of cells for monitoring HIV‐1 positive individuals and predicting HIV‐1 phenotype.
Author Bocket-Mouton, Laurence
De Groote, Donat
Wattré, Pierre
Benyoucef, Samira
Vilain, Virginie
Hober, Didier
Gérard, Yann
Ajana, Faïza
Lion, Georges
Shen, Lu
Author_xml – sequence: 1
  givenname: Samira
  surname: Benyoucef
  fullname: Benyoucef, Samira
  organization: Laboratoire de Virologie, CHU, 59037, Lille Cedex, France
– sequence: 2
  givenname: Didier
  surname: Hober
  fullname: Hober, Didier
  organization: Laboratoire de Virologie, CHU, 59037, Lille Cedex, France
– sequence: 3
  givenname: Lu
  surname: Shen
  fullname: Shen, Lu
  organization: Laboratoire de Virologie, CHU, 59037, Lille Cedex, France
– sequence: 4
  givenname: Faïza
  surname: Ajana
  fullname: Ajana, Faïza
  organization: Service Régional des Maladies Infectieuses, Hôpital Dron, Tourcoing, France
– sequence: 5
  givenname: Donat
  surname: De Groote
  fullname: De Groote, Donat
  organization: Medgenix Diagnostics, S. A., Research and Development Department, Fleurus, Belgium
– sequence: 6
  givenname: Laurence
  surname: Bocket-Mouton
  fullname: Bocket-Mouton, Laurence
  organization: Service Régional des Maladies Infectieuses, Hôpital Dron, Tourcoing, France
– sequence: 7
  givenname: Yann
  surname: Gérard
  fullname: Gérard, Yann
  organization: Service Régional des Maladies Infectieuses, Hôpital Dron, Tourcoing, France
– sequence: 8
  givenname: Georges
  surname: Lion
  fullname: Lion, Georges
  organization: Centre Hospitalier, Valenciennes, France
– sequence: 9
  givenname: Virginie
  surname: Vilain
  fullname: Vilain, Virginie
  organization: Centre Hospitalier, Valenciennes, France
– sequence: 10
  givenname: Pierre
  surname: Wattré
  fullname: Wattré, Pierre
  organization: Laboratoire de Virologie, CHU, 59037, Lille Cedex, France
BackLink https://cir.nii.ac.jp/crid/1570009753174902912$$DView record in CiNii
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2184755$$DView record in Pascal Francis
BookMark eNqVkt9u0zAUxiM0JLrBO1gIcZdix3Fi74ptZV3F_gkKk7ixXOeEuKR2iV3WPhHXvAjPhLNWBXG3XDiOz-98n-PPh8mBdRaS5CXBQxKfN_MhoTlPcZ6RIRGiHIYZJoLR4fpJMtiXDpIBppylrMD4WXLo_RzjrMx4Pkh-3nauWulgnEWuRtPr89-_kLIVmlymBZpt0Ems_VABKnTXuBbQaetcherOLdDF5HNK0MTWoPv6rQoGbPBoBGG7EtsVurGQfgzqK6BopaFadXCMPkCrek_fmCW6N6FBoYlAA9aFzRL6rezUvYsk-OfJ01q1Hl7s3kfJp_N307OL9PJmPDk7uUw1w4KmHHORz5iq2IwWmDBegcqyqihyoatc64yVhALwmc7iJydQVwCFqFnFAZOC06Pk9VZ32bnvK_BBLozX0LbKglt5SQpaEk568NUOVF6rtu6U1cbLZWcWqtvIjPC8ZCxix1tMd877Duo9QbDsI5Rz2eck-5xkH6HcRSjXsfntf83ahIdzC50y7aMk7k0Lm0eYy6vJ1cP0759aY-IG-pGwEmMsSkZJmQucCZJFbLzF5r5Pe2-lumB0C3IRb5UhoixlHr2y3Sio2BO6UZ0EG5XSrZLxAdb_CH2TRUlLJu-ux_KUi9H0CxvJ9_QPUoLs-A
CODEN MIIMDV
CitedBy_id crossref_primary_10_1073_pnas_0507577102
crossref_primary_10_1089_107999001753124426
crossref_primary_10_1016_S0753_3322_00_00018_4
Cites_doi 10.4049/jimmunol.148.11.3505
10.1172/JCI115493
10.1111/j.1348-0421.1996.tb01083.x
10.1007/BF00915059
10.1007/BF00211217
10.1016/0090-1229(92)90069-Z
10.1126/science.2832945
10.1111/j.1348-0421.1993.tb01706.x
10.1016/0002-9343(88)90576-1
10.1016/S0140-6736(86)90169-8
10.4049/jimmunol.144.2.480
10.1126/science.3277274
10.1016/1043-4666(92)90062-V
10.1016/1043-4666(92)90021-I
10.1016/0022-1759(93)90130-Y
10.1097/00002030-199112000-00001
10.1016/0090-1229(90)90001-7
10.1016/0090-1229(89)90144-X
10.1111/j.1365-2249.1993.tb03349.x
10.1016/0022-1759(91)90188-L
10.4049/jimmunol.141.1.99
10.1016/S0140-6736(87)90826-9
10.1089/aid.1989.5.139
10.1089/aid.1991.7.381
10.1097/00126334-199212000-00010
ContentType Journal Article
Copyright Center for Academic Publications Japan
owned by Center for Academic Publications Japan (Publisher)
1998 INIST-CNRS
Copyright_xml – notice: Center for Academic Publications Japan
– notice: owned by Center for Academic Publications Japan (Publisher)
– notice: 1998 INIST-CNRS
DBID BSCLL
RYH
AAYXX
CITATION
IQODW
7T5
7U9
H94
DOI 10.1111/j.1348-0421.1997.tb01953.x
DatabaseName Istex
CiNii Complete
CrossRef
Pascal-Francis
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts



CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1348-0421
EndPage 946
ExternalDocumentID 2184755
10_1111_j_1348_0421_1997_tb01953_x
MIM01953
130003484464
article_mandi1977_41_12_41_12_939_article_char_en
ark_67375_WNG_B89DTZ5D_K
Genre article
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
123
1OC
24P
29M
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5HH
5LA
5RE
5VS
7.U
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
A8Z
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-E
D-F
DCZOG
DIK
DPXWK
DRFUL
DRSTM
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
ESTFP
F00
F01
F04
F5P
FEDTE
G-S
G.N
GODZA
H.T
H.X
HF~
HGLYW
HVGLF
HZ~
J0M
JSF
JSH
KQ8
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MM.
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJT
ROL
RX1
RZJ
SJN
SUPJJ
SV3
TEORI
TKC
TWZ
UB1
V8K
W8V
W99
WBKPD
WHG
WIH
WIK
WIN
WNSPC
WOHZO
WXSBR
WYISQ
X7M
XG1
XOL
XSB
ZGI
ZXP
ZZTAW
~IA
~WT
1OB
AAHQN
AAMMB
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AEFGJ
AEYWJ
AFWVQ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
ALVPJ
OVT
RYH
AAYXX
CITATION
IQODW
7T5
7U9
H94
ID FETCH-LOGICAL-c5093-80894b5ad5b360158dea22d6649cd4cc25713ee8bc2d4c81efdee69f5d8e01683
ISSN 0385-5600
IngestDate Sun Aug 24 04:04:11 EDT 2025
Mon Jul 21 09:16:24 EDT 2025
Thu Apr 24 23:12:00 EDT 2025
Tue Jul 01 02:26:02 EDT 2025
Wed Jan 22 16:40:58 EST 2025
Thu Jun 26 22:36:33 EDT 2025
Wed Sep 03 06:10:02 EDT 2025
Wed Oct 30 09:53:32 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Human
Immunopathology
HIV-1 virus
Cytokine
Retroviridae
AIDS
Immune deficiency
Lentivirus
Host virus relation
Infection
Virus
Interleukin 6
Whole blood
Phenotype
Viral disease
Human immunodeficiency virus
Tumor necrosis factor α
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5093-80894b5ad5b360158dea22d6649cd4cc25713ee8bc2d4c81efdee69f5d8e01683
Notes ark:/67375/WNG-B89DTZ5D-K
istex:03CFB2A115FB4A6591E984DA85E6481DFC978A71
ArticleID:MIM01953
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/mandi1977/41/12/41_12_939/_article/-char/en
PQID 16371818
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_16371818
pascalfrancis_primary_2184755
crossref_primary_10_1111_j_1348_0421_1997_tb01953_x
crossref_citationtrail_10_1111_j_1348_0421_1997_tb01953_x
wiley_primary_10_1111_j_1348_0421_1997_tb01953_x_MIM01953
nii_cinii_1570009753174902912
jstage_primary_article_mandi1977_41_12_41_12_939_article_char_en
istex_primary_ark_67375_WNG_B89DTZ5D_K
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1997-01-01
PublicationDateYYYYMMDD 1997-01-01
PublicationDate_xml – month: 01
  year: 1997
  text: 1997-01-01
  day: 01
PublicationDecade 1990
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
PublicationTitle MICROBIOLOGY and IMMUNOLOGY
PublicationTitleAlternate Microbiology and Immunology
PublicationTitle_FL Japanese Journal of Microbiology
PublicationYear 1997
Publisher Blackwell Publishing Ltd
Center For Academic Publications Japan
Center for Academic Publications Japan
Publisher_xml – name: Blackwell Publishing Ltd
– name: Center For Academic Publications Japan
– name: Center for Academic Publications Japan
References Matsuyama, T., Kobayashi, N., and Yamamoto, N. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417.
Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J.-P., and Cavaillon, J.-M. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754.
Elsässer-Beile, U., Von Kleist, S., and Gallati, H. 1991. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 139: 191.
Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240: 80-82.
Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. Infection with HIV is associated with elevated Il-6 levels and production. J. Immunol. 144: 480-484.
Jones, P.D., Shelley, L., and Wakefield, D. 1992. Tumor necrosis factor-α in advanced HIV in the absence of AIDS-related secondary infections. J. Acq. Immun. Defic. Syndr. 5: 1266-1271.
Amman, A., and Palladino, M.A. 1987. Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS-related complex. J. Clin. Immunol. 7: 481-485.
Anand, R., Siegal, F., Reed, C., Cheung, T., Forlenza, S., and Moor, J. 1987. Non-cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders. Lancet ii: 234-238.
Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622.
Lahdevista, J., Maury, C.P.J., Teppo, A., and Repo, H. 1988. Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291.
Hober, D., Lucas, B., Wattré, P., Capron, A., and Haque, A. 1992. TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62: 168-175.
Roux-Lombard, P., Modoux, C., Cruchaud, A., and Dayer, J.-M. 1989. Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50: 374-384.
Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Soma, G.-I., Mizuno, D., and Kobayashi, N. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5: 139-143.
Wright, S.C., Jewett, A., Mitsuyasu, R., and Bonavida, B. 1988. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141: 99-104.
Zangerle, P.F., Degroote, D., Lopez, M., Meuleman, R.J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1992. Direct stimulation of cytokines (***Il-1β, TNF-α, Il-6, Il-2, IFNγ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575.
Lathey, J.L., Agosti, J.M., Nelson, J.A., Corey, L., Gregory, S.A., Morrissey, J.H., Edgington, T.S., and Oldstone, M.B.A. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54: 1-13.
Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., and Wattré, P. 1996. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40: 381-388.
Allen, J.N., Herzyk, D.J., Allen, E.D., and Wewers, M.D. 1992. Human whole blood interleukin-1-β production: kinetics, cell source and comparison with TNFα. J. Lab. Clin. Med. 119: 538-546.
Steffen, M., Reinecker, H.C., Peterson, J., Doehn, C., Pflüger, I., Voss, A., and Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-1-infected patients. Clin. Exp. Immunol. 91: 30-36.
Centers for Diseases Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334-339.
Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.-P., and Baumgartner, J.D. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148: 3505-3512.
Degroote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., and Franchimont, P. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248.
Hober, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333.
Desch, C.E., Kovach, N.L., Present, W., Broyles, C., and Harlan, J.M. 1989. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 8: 141-145.
Alagara, S.D.S., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dignero, G. 1991. Serum levels of Il-2, Il-1 and TNFα and soluble receptor of Il-2 in HIV-1 infected patients. AIDS Res. Hum. Retroviruses 7: 381-386.
Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., and Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792.
Matsuyama, T., Hamamoto, Y., Kurimoto, M., Minowada, J., Kobayashi, N., and Yamamoto, N. 1988. Enhancement of human immunodeficiency virus production of natural lymphotoxin. Med. Microbiol. Immunol. 177: 181-187.
Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Fenyö, E.M. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii: 660-662.
Lathey, J.L., Kanangat, S., and Rouse, B.T. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction. J. Acq. Immun. Defic. Syndr. 7: 109-115.
Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1993. Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267.
13) Elsässer-Beile, U., Von Kleist, S., and Gallati, H. 1991. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 139: 191.
1) Alagara, S.D.S., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dignero, G. 1991. Serum levels of II-2, II-1 and TNFα and soluble receptor of II-2 in HIV-1 infected patients. AIDS Res. Hum. Retroviruses 7: 381-386.
9) Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240: 80-82.
17) Holier, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333.
6) Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., and Wattré, P. 1996. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40: 381-388.
24) Matsuyama, T., Kobayashi, N., and Yamamoto, N. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417.
22) Lathey, J.L., Kanangat, S., and Rouse, B.T. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes form human immunodeficiency virus-positive individuals measured by polymerise chain reaction. J. Acq. Immun. Defic. Syndr. 7: 109-115.
4) Anand, R., Siegal, E, Reed, C., Cheung, T., Forlenza, S., and Moor, J. 1987. Non-cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders. Lancet ii: 234-238.
23) Matsuyama, T., Hamamoto, Y., Kurimoto, M., Minowada, J., Kobayashi, N., and Yamamoto, N. 1988. Enhancement of human immunodeficiency virus production of natural lymphotoxin. Med. Microbiol. Immunol. 177: 181-187.
28) Steffen, M., Reinecker, H.C., Peterson, J., Doehn, C., Pflüger, I., Voss, A., and Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-1-infected patients. Clin. Exp. Immunol. 91: 30-36.
2) Allen, J.N., Herzyk, D.J., Allen, E.D., and Wewers, M.D. 1992. Human whole blood interleukin-1-β production: kinetics, cell source and comparison with TNFα. J. Lab. Clin. Med. 119: 538-546.
26) Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J.-P., and Cavaillon, J.-M. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754.
11) Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1993. Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267.
3) Amman, A., and Palladino, M.A. 1987. Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS-related complex. J. Clin. Immunol. 7: 481-485.
20) Lahdevista, J., Maury, C.P.J., Teppo, A., and Repo, H. 1988. Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291.
14) Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622.
12) Desch, C.E., Kovach, N.L., Present, W., Broyles, C., and Harlan, J.M. 1989. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 8: 141-145.
8) Centers for Diseases Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334-339.
10) Degroote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., and Franchimont, P. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248.
19) Jones, P.D., Shelley, L., and Wakefield, D. 1992. Tumor necrosis factor-α in advanced HIV in the absence of AIDS-related secondary infections. J. Acq. Immun. Defic. Syndr. 5: 1266-1271.
5) Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Fenyö, E.M. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii: 660-662.
30) Zangerle, P.F., Degroote, D., Lopez, M., Meuleman, R.J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1992. Direct stimulation of cytokines (II-1β, TNF-α, II-6, II-2, IFNγ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575.
25) Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Soma, G.-I., Mizuno, D., and Kobayashi, N. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5: 139-143.
16) Hober, D., Lucas, B., Wattré, P., Capron, A., and Haque, A. 1992. TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62: 168-175.
29) Wright, S.C., Jewett, A., Mitsuyasu, R., and Bonavida, B. 1988. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141: 99-104.
7) Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. Infection with HIV is associated with elevated II-6 levels and production. J. Immunol. 144: 480-484.
18) Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., and Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792.
21) Lathey, J.L., Agosti, J.M., Nelson, J.A., Corey, L., Gregory, S.A., Morrissey, J.H., Edgington, T.S., and Oldstone, M.B.A. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54: 1-13.
27) Roux-Lombard, P., Modoux, C., Cruchaud, A., and Dayer, J.-M. 1989. Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50: 374-384.
15) Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.-P., and Baumgartner, J.D. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148: 3505-3512.
1987; ii
1989; 5
1990; 54
1986; ii
1986; 35
1987; 7
1989; 8
1992; 148
1993; 163
1993; 91
1988; 240
1988; 141
1991; 139
1990; 144
1991; 7
1991; 5
1993; 37
1989; 50
1989; 78
1991; 88
1992; 119
1996; 40
1988; 177
1988; 85
1988; 239
1992; 4
1992; 62
1994; 7
1992; 5
e_1_2_2_4_1
e_1_2_2_25_1
e_1_2_2_5_1
e_1_2_2_24_1
e_1_2_2_6_1
e_1_2_2_7_1
e_1_2_2_22_1
e_1_2_2_21_1
Wright S.C. (e_1_2_2_30_1) 1988; 141
e_1_2_2_20_1
e_1_2_2_2_1
Heumann D. (e_1_2_2_16_1) 1992; 148
Desch C.E. (e_1_2_2_13_1) 1989; 8
e_1_2_2_29_1
e_1_2_2_28_1
e_1_2_2_27_1
e_1_2_2_26_1
(e_1_2_2_9_1) 1986; 35
e_1_2_2_14_1
Breen E.C. (e_1_2_2_8_1) 1990; 144
e_1_2_2_12_1
e_1_2_2_11_1
e_1_2_2_10_1
Allen J.N. (e_1_2_2_3_1) 1992; 119
e_1_2_2_31_1
e_1_2_2_19_1
Hober D. (e_1_2_2_18_1) 1989; 78
e_1_2_2_17_1
e_1_2_2_15_1
Lathey J.L. (e_1_2_2_23_1) 1994; 7
References_xml – reference: Alagara, S.D.S., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dignero, G. 1991. Serum levels of Il-2, Il-1 and TNFα and soluble receptor of Il-2 in HIV-1 infected patients. AIDS Res. Hum. Retroviruses 7: 381-386.
– reference: Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622.
– reference: Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240: 80-82.
– reference: Centers for Diseases Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334-339.
– reference: Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., and Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792.
– reference: Degroote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., and Franchimont, P. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248.
– reference: Wright, S.C., Jewett, A., Mitsuyasu, R., and Bonavida, B. 1988. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141: 99-104.
– reference: Hober, D., Lucas, B., Wattré, P., Capron, A., and Haque, A. 1992. TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62: 168-175.
– reference: Lathey, J.L., Agosti, J.M., Nelson, J.A., Corey, L., Gregory, S.A., Morrissey, J.H., Edgington, T.S., and Oldstone, M.B.A. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54: 1-13.
– reference: Elsässer-Beile, U., Von Kleist, S., and Gallati, H. 1991. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 139: 191.
– reference: Roux-Lombard, P., Modoux, C., Cruchaud, A., and Dayer, J.-M. 1989. Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50: 374-384.
– reference: Anand, R., Siegal, F., Reed, C., Cheung, T., Forlenza, S., and Moor, J. 1987. Non-cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders. Lancet ii: 234-238.
– reference: Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Fenyö, E.M. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii: 660-662.
– reference: Matsuyama, T., Hamamoto, Y., Kurimoto, M., Minowada, J., Kobayashi, N., and Yamamoto, N. 1988. Enhancement of human immunodeficiency virus production of natural lymphotoxin. Med. Microbiol. Immunol. 177: 181-187.
– reference: Steffen, M., Reinecker, H.C., Peterson, J., Doehn, C., Pflüger, I., Voss, A., and Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-1-infected patients. Clin. Exp. Immunol. 91: 30-36.
– reference: Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Soma, G.-I., Mizuno, D., and Kobayashi, N. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5: 139-143.
– reference: Allen, J.N., Herzyk, D.J., Allen, E.D., and Wewers, M.D. 1992. Human whole blood interleukin-1-β production: kinetics, cell source and comparison with TNFα. J. Lab. Clin. Med. 119: 538-546.
– reference: Matsuyama, T., Kobayashi, N., and Yamamoto, N. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417.
– reference: Jones, P.D., Shelley, L., and Wakefield, D. 1992. Tumor necrosis factor-α in advanced HIV in the absence of AIDS-related secondary infections. J. Acq. Immun. Defic. Syndr. 5: 1266-1271.
– reference: Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J.-P., and Cavaillon, J.-M. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754.
– reference: Desch, C.E., Kovach, N.L., Present, W., Broyles, C., and Harlan, J.M. 1989. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 8: 141-145.
– reference: Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., and Wattré, P. 1996. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40: 381-388.
– reference: Lahdevista, J., Maury, C.P.J., Teppo, A., and Repo, H. 1988. Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291.
– reference: Amman, A., and Palladino, M.A. 1987. Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS-related complex. J. Clin. Immunol. 7: 481-485.
– reference: Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. Infection with HIV is associated with elevated Il-6 levels and production. J. Immunol. 144: 480-484.
– reference: Zangerle, P.F., Degroote, D., Lopez, M., Meuleman, R.J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1992. Direct stimulation of cytokines (***Il-1β, TNF-α, Il-6, Il-2, IFNγ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575.
– reference: Hober, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333.
– reference: Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.-P., and Baumgartner, J.D. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148: 3505-3512.
– reference: Lathey, J.L., Kanangat, S., and Rouse, B.T. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction. J. Acq. Immun. Defic. Syndr. 7: 109-115.
– reference: Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1993. Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267.
– reference: 18) Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., and Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792.
– reference: 6) Benyoucef, S., Hober, D., Shen, L., Ajana, F., Gérard, Y., Bocket-Mouton, L., Mouton, Y., and Wattré, P. 1996. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates. Microbiol. Immunol. 40: 381-388.
– reference: 14) Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622.
– reference: 27) Roux-Lombard, P., Modoux, C., Cruchaud, A., and Dayer, J.-M. 1989. Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50: 374-384.
– reference: 30) Zangerle, P.F., Degroote, D., Lopez, M., Meuleman, R.J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1992. Direct stimulation of cytokines (II-1β, TNF-α, II-6, II-2, IFNγ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575.
– reference: 15) Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R.J., Tobias, P.S., Glauser, M.-P., and Baumgartner, J.D. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148: 3505-3512.
– reference: 17) Holier, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333.
– reference: 20) Lahdevista, J., Maury, C.P.J., Teppo, A., and Repo, H. 1988. Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291.
– reference: 1) Alagara, S.D.S., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dignero, G. 1991. Serum levels of II-2, II-1 and TNFα and soluble receptor of II-2 in HIV-1 infected patients. AIDS Res. Hum. Retroviruses 7: 381-386.
– reference: 25) Matsuyama, T., Yoshiyama, H., Amamoto, Y., Yamamoto, N., Soma, G.-I., Mizuno, D., and Kobayashi, N. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses 5: 139-143.
– reference: 10) Degroote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., and Franchimont, P. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4: 239-248.
– reference: 5) Asjo, B., Morfeldt-Mansson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Fenyö, E.M. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections. Lancet ii: 660-662.
– reference: 11) Degroote, D., Gevaert, Y., Lopez, M., Gathy, R., Fauchet, F., Dehart, I., Jadoul, M., Radoux, D., and Franchimont, P. 1993. Novel method for the measurement of cytokine production by a one-stage procedure. J. Immunol. Methods 163: 259-267.
– reference: 4) Anand, R., Siegal, E, Reed, C., Cheung, T., Forlenza, S., and Moor, J. 1987. Non-cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders. Lancet ii: 234-238.
– reference: 2) Allen, J.N., Herzyk, D.J., Allen, E.D., and Wewers, M.D. 1992. Human whole blood interleukin-1-β production: kinetics, cell source and comparison with TNFα. J. Lab. Clin. Med. 119: 538-546.
– reference: 21) Lathey, J.L., Agosti, J.M., Nelson, J.A., Corey, L., Gregory, S.A., Morrissey, J.H., Edgington, T.S., and Oldstone, M.B.A. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54: 1-13.
– reference: 13) Elsässer-Beile, U., Von Kleist, S., and Gallati, H. 1991. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J. Immunol. Methods 139: 191.
– reference: 24) Matsuyama, T., Kobayashi, N., and Yamamoto, N. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5: 1405-1417.
– reference: 19) Jones, P.D., Shelley, L., and Wakefield, D. 1992. Tumor necrosis factor-α in advanced HIV in the absence of AIDS-related secondary infections. J. Acq. Immun. Defic. Syndr. 5: 1266-1271.
– reference: 26) Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J.-P., and Cavaillon, J.-M. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754.
– reference: 9) Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. 1988. Biological features of HIV-1 that correlate with virulence in the host. Science 240: 80-82.
– reference: 28) Steffen, M., Reinecker, H.C., Peterson, J., Doehn, C., Pflüger, I., Voss, A., and Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-1-infected patients. Clin. Exp. Immunol. 91: 30-36.
– reference: 7) Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. 1990. Infection with HIV is associated with elevated II-6 levels and production. J. Immunol. 144: 480-484.
– reference: 3) Amman, A., and Palladino, M.A. 1987. Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS-related complex. J. Clin. Immunol. 7: 481-485.
– reference: 29) Wright, S.C., Jewett, A., Mitsuyasu, R., and Bonavida, B. 1988. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141: 99-104.
– reference: 8) Centers for Diseases Control. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 35: 334-339.
– reference: 12) Desch, C.E., Kovach, N.L., Present, W., Broyles, C., and Harlan, J.M. 1989. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 8: 141-145.
– reference: 16) Hober, D., Lucas, B., Wattré, P., Capron, A., and Haque, A. 1992. TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62: 168-175.
– reference: 23) Matsuyama, T., Hamamoto, Y., Kurimoto, M., Minowada, J., Kobayashi, N., and Yamamoto, N. 1988. Enhancement of human immunodeficiency virus production of natural lymphotoxin. Med. Microbiol. Immunol. 177: 181-187.
– reference: 22) Lathey, J.L., Kanangat, S., and Rouse, B.T. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes form human immunodeficiency virus-positive individuals measured by polymerise chain reaction. J. Acq. Immun. Defic. Syndr. 7: 109-115.
– volume: 85
  start-page: 289
  year: 1988
  end-page: 291
  article-title: Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome
  publication-title: Am. J. Med.
– volume: 50
  start-page: 374
  year: 1989
  end-page: 384
  article-title: Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL‐1
  publication-title: Clin. Immunol. Immunopathol.
– volume: 4
  start-page: 239
  year: 1992
  end-page: 248
  article-title: Direct stimulation of cytokines (IL‐1 beta, TNF‐alpha, IL‐6, IFN‐gamma and GM‐CSF) in whole blood: I. Comparison with isolated PBMC stimulation
  publication-title: Cytokine
– volume: 144
  start-page: 480
  year: 1990
  end-page: 484
  article-title: Infection with HIV is associated with elevated Il‐6 levels and production
  publication-title: J. Immunol.
– volume: 7
  start-page: 481
  year: 1987
  end-page: 485
  article-title: Tumor necrosis factor alpha and beta in acquired immunodeficiency (AIDS) and AIDS‐related complex
  publication-title: J. Clin. Immunol.
– volume: 141
  start-page: 99
  year: 1988
  end-page: 104
  article-title: Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients
  publication-title: J. Immunol.
– volume: 40
  start-page: 381
  year: 1996
  end-page: 388
  article-title: A microassay for determination of the cytopathogenicity of human immunodeficiency virus type‐1 isolates
  publication-title: Microbiol. Immunol.
– volume: 37
  start-page: 785
  year: 1993
  end-page: 792
  article-title: Granulocyte‐macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection
  publication-title: Microbiol. Immunol.
– volume: 5
  start-page: 1405
  year: 1991
  end-page: 1417
  article-title: Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?
  publication-title: AIDS
– volume: 78
  start-page: 329
  year: 1989
  end-page: 333
  article-title: Production of tumor necrosis factor (TNFα) and interleukin‐1 (IL‐1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity
  publication-title: Clin. Exp. Immunol.
– volume: 119
  start-page: 538
  year: 1992
  end-page: 546
  article-title: Human whole blood interleukin‐1‐β production: kinetics, cell source and comparison with TNFα
  publication-title: J. Lab. Clin. Med.
– volume: 54
  start-page: 1
  year: 1990
  end-page: 13
  article-title: A selective defect in tissue factor mRNA expression in monocytes from AIDS patients
  publication-title: Clin. Immunol. Immunopathol.
– volume: 4
  start-page: 568
  year: 1992
  end-page: 575
  article-title: Direct stimulation of cytokines (***Il‐1β, TNF‐α, Il‐6, Il‐2, IFNγ, and GM‐CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis
  publication-title: Cytokine
– volume: 240
  start-page: 80
  year: 1988
  end-page: 82
  article-title: Biological features of HIV‐1 that correlate with virulence in the host
  publication-title: Science
– volume: 239
  start-page: 617
  year: 1988
  end-page: 622
  article-title: The human immunodeficiency virus: infectivity and mechanisms of pathogenesis
  publication-title: Science
– volume: 8
  start-page: 141
  year: 1989
  end-page: 145
  article-title: Production of human tumor necrosis factor from whole blood ex vivo
  publication-title: Lymphokine Res.
– volume: 62
  start-page: 168
  year: 1992
  end-page: 175
  article-title: TNFα production by U937 promonocytes is enhanced by factors released from HIV‐infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV‐infected T4 cells
  publication-title: Clin. Immunol. Immunopathol.
– volume: 91
  start-page: 30
  year: 1993
  end-page: 36
  article-title: Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV‐1‐infected patients
  publication-title: Clin. Exp. Immunol.
– volume: 139
  start-page: 191
  year: 1991
  article-title: Evaluation of a test system for measuring cytokine production in human whole blood cell cultures
  publication-title: J. Immunol. Methods
– volume: ii
  start-page: 234
  year: 1987
  end-page: 238
  article-title: Non‐cytocidal natural variants of human immunodeficiency virus from AIDS patients with neurological disorders
  publication-title: Lancet
– volume: 7
  start-page: 381
  year: 1991
  end-page: 386
  article-title: Serum levels of Il‐2, Il‐1 and TNFα and soluble receptor of Il‐2 in HIV‐1 infected patients
  publication-title: AIDS Res. Hum. Retroviruses
– volume: 88
  start-page: 1747
  year: 1991
  end-page: 1754
  article-title: Dysregulation of in vitro cytokine production by monocytes during sepsis
  publication-title: J. Clin. Invest.
– volume: 5
  start-page: 1266
  year: 1992
  end-page: 1271
  article-title: Tumor necrosis factor‐α in advanced HIV in the absence of AIDS‐related secondary infections
  publication-title: J. Acq. Immun. Defic. Syndr.
– volume: 5
  start-page: 139
  year: 1989
  end-page: 143
  article-title: Enhancement of HIV replication and giant cell formation by tumor necrosis factor
  publication-title: AIDS Res. Hum. Retroviruses
– volume: 7
  start-page: 109
  year: 1994
  end-page: 115
  article-title: Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus‐positive individuals measured by polymerase chain reaction
  publication-title: J. Acq. Immun. Defic. Syndr.
– volume: 35
  start-page: 334
  year: 1986
  end-page: 339
  article-title: Classification system for human T‐lymphotropic virus type III/lymphadenopathy‐associated virus infection
  publication-title: MMWR
– volume: 148
  start-page: 3505
  year: 1992
  end-page: 3512
  article-title: Control of lipopolysaccharide (LPS) binding and LPS‐induced tumor necrosis factor secretion in human peripheral blood monocytes
  publication-title: J. Immunol.
– volume: ii
  start-page: 660
  year: 1986
  end-page: 662
  article-title: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infections
  publication-title: Lancet
– volume: 163
  start-page: 259
  year: 1993
  end-page: 267
  article-title: Novel method for the measurement of cytokine production by a one‐stage procedure
  publication-title: J. Immunol. Methods
– volume: 177
  start-page: 181
  year: 1988
  end-page: 187
  article-title: Enhancement of human immunodeficiency virus production of natural lymphotoxin
  publication-title: Med. Microbiol. Immunol.
– volume: 148
  start-page: 3505
  year: 1992
  ident: e_1_2_2_16_1
  article-title: Control of lipopolysaccharide (LPS) binding and LPS‐induced tumor necrosis factor secretion in human peripheral blood monocytes
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.148.11.3505
– ident: e_1_2_2_27_1
  doi: 10.1172/JCI115493
– ident: e_1_2_2_7_1
  doi: 10.1111/j.1348-0421.1996.tb01083.x
– ident: e_1_2_2_4_1
  doi: 10.1007/BF00915059
– ident: e_1_2_2_24_1
  doi: 10.1007/BF00211217
– ident: e_1_2_2_17_1
  doi: 10.1016/0090-1229(92)90069-Z
– ident: e_1_2_2_10_1
  doi: 10.1126/science.2832945
– ident: e_1_2_2_19_1
  doi: 10.1111/j.1348-0421.1993.tb01706.x
– ident: e_1_2_2_21_1
  doi: 10.1016/0002-9343(88)90576-1
– ident: e_1_2_2_6_1
  doi: 10.1016/S0140-6736(86)90169-8
– volume: 144
  start-page: 480
  year: 1990
  ident: e_1_2_2_8_1
  article-title: Infection with HIV is associated with elevated Il‐6 levels and production
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.144.2.480
– ident: e_1_2_2_15_1
  doi: 10.1126/science.3277274
– ident: e_1_2_2_11_1
  doi: 10.1016/1043-4666(92)90062-V
– ident: e_1_2_2_31_1
  doi: 10.1016/1043-4666(92)90021-I
– ident: e_1_2_2_12_1
  doi: 10.1016/0022-1759(93)90130-Y
– ident: e_1_2_2_25_1
  doi: 10.1097/00002030-199112000-00001
– volume: 35
  start-page: 334
  year: 1986
  ident: e_1_2_2_9_1
  article-title: Classification system for human T‐lymphotropic virus type III/lymphadenopathy‐associated virus infection
  publication-title: MMWR
– ident: e_1_2_2_22_1
  doi: 10.1016/0090-1229(90)90001-7
– ident: e_1_2_2_28_1
  doi: 10.1016/0090-1229(89)90144-X
– volume: 78
  start-page: 329
  year: 1989
  ident: e_1_2_2_18_1
  article-title: Production of tumor necrosis factor (TNFα) and interleukin‐1 (IL‐1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity
  publication-title: Clin. Exp. Immunol.
– ident: e_1_2_2_29_1
  doi: 10.1111/j.1365-2249.1993.tb03349.x
– ident: e_1_2_2_14_1
  doi: 10.1016/0022-1759(91)90188-L
– volume: 7
  start-page: 109
  year: 1994
  ident: e_1_2_2_23_1
  article-title: Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus‐positive individuals measured by polymerase chain reaction
  publication-title: J. Acq. Immun. Defic. Syndr.
– volume: 8
  start-page: 141
  year: 1989
  ident: e_1_2_2_13_1
  article-title: Production of human tumor necrosis factor from whole blood ex vivo
  publication-title: Lymphokine Res.
– volume: 141
  start-page: 99
  year: 1988
  ident: e_1_2_2_30_1
  article-title: Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.141.1.99
– ident: e_1_2_2_5_1
  doi: 10.1016/S0140-6736(87)90826-9
– ident: e_1_2_2_26_1
  doi: 10.1089/aid.1989.5.139
– ident: e_1_2_2_2_1
  doi: 10.1089/aid.1991.7.381
– ident: e_1_2_2_20_1
  doi: 10.1097/00126334-199212000-00010
– volume: 119
  start-page: 538
  year: 1992
  ident: e_1_2_2_3_1
  article-title: Human whole blood interleukin‐1‐β production: kinetics, cell source and comparison with TNFα
  publication-title: J. Lab. Clin. Med.
SSID ssj0027284
Score 1.4919283
Snippet Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL-6 production using...
Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL‐6 production using...
Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNFα and IL‐6 production using...
Diluted whole blood (WB) culturing may be the most appropriate milieu in which to study cytokine production in vitro. We tested TNF alpha and IL-6 production...
SourceID proquest
pascalfrancis
crossref
wiley
nii
jstage
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 939
SubjectTerms Biological and medical sciences
Fundamental and applied biological sciences. Psychology
HIV-1
Human viral diseases
IL-6
Infectious diseases
Medical sciences
Microbiology
P4 cells
Patients
Phenotype
Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains
TNFα
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Virology
Whole blood
Title Production of TNFα and IL-6 by Activated Whole Blood from HIV-1 Infected Patients Detected by a One-Stage Procedure: Relationship with the Phenotype of HIV-1 Isolates
URI https://api.istex.fr/ark:/67375/WNG-B89DTZ5D-K/fulltext.pdf
https://www.jstage.jst.go.jp/article/mandi1977/41/12/41_12_939/_article/-char/en
https://cir.nii.ac.jp/crid/1570009753174902912
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1348-0421.1997.tb01953.x
https://www.proquest.com/docview/16371818
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX MICROBIOLOGY and IMMUNOLOGY, 1997, Vol.41(12), pp.939-946
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKLkhcEE9RYMEHxKUKWufpcIKlW1q2LRxaWHGxEseBLpCiPoDya7jzJ5mxnTRBrNjlYqVO7KSZz_bMZL4xIQ-jIEgjmacOLAc5GChMwpCKQyd3E9BOYy_hGTr0R-OwP_VfHgfHrdbPWtTSepU-lj_-yiv5H6lCHcgVWbLnkGzVKVTAMcgXSpAwlGeS8WuTrtXqfJNxr6OpsybGd-iEqFsiceFrgnrlN9wK10SqG1ZJf_DGYTYcC87bFKvLTqZWpgabd-aFckCFfI-MKljssvVCNaLoMNrLeHORdPVBFXPt1sUPBKZ_eAeo0NbV4NHsz_xPSFNpePgPVLGZA-7yhn-2j4HgzUBlSy8ZrivsniSG6NbbujRMOtjKpWGpXDxwUBWrT9M-q8PRrU26sUmHZNfv2Lg0T18aPJ87MFUxJGpG6BnHL4ll0Gg9H_f4lehNh0MxOTyeXCC7LhgiOPV3B0dbk97lJkGZfWCb1tbGip1yp4YKtIujGaounmhRgopTzGYYoZssYZDmZneVhvlTN6K0FjS5Sq5Y84U-M1i8RlqquE4umQ1NNzfIry0i6TyngEiqEUlBxhQRSdMNrRBJNSKpRiRFRFKNGFoikpaIpCUidXNaIZJWiHxC63ikiEcKeKQVHvFxbO8WjzfJtHc4ed537HYgjgSt1gNdisd-GiRZkHohaLE8U4nrZmHoxzLzpYTFh3lK8VS68JMzlWdKhXEeZFyBYcO9W2SngCe8TWiSh3kaxgmTievzTKaBJyVjWRC5uUzDtE3iUkJC2lz5uGXLJ1GzmUG6AqUrULrCSld8bxOvavvFZIw5U6tHGghVk2TxEWMuo0C8Hb8QBzzuTt4FXXHUJk8NUmpXapGLz8iDY2DPCR96d20Jg6O6AomcMG-2yR5gDP4Ylgw3uNhHej2L_HjfjZkL5xvoq-6E7iCY3NvkQYlGAYsRfmFMCjVfLwUYd6DrMg7vT4P0HC9AjAYjfXjnn73fJZe3s8Y9srNarNUemAar9L4enb8BCA0JEA
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Production+of+TNF+alpha+and+IL-6+by+activated+whole+blood+from+HIV-1+infected+patients+detected+by+a+one-stage+procedure%3A+Relationship+with+the+phenotype+of+HIV-1+isolates&rft.jtitle=Microbiology+and+immunology&rft.au=Benyoucef%2C+S&rft.au=Hober%2C+D&rft.au=Shen%2C+Lu&rft.au=Ajana%2C+F&rft.date=1997-01-01&rft.issn=0385-5600&rft.volume=41&rft.issue=12&rft.spage=939&rft.epage=946&rft_id=info:doi/10.1111%2Fj.1348-0421.1997.tb01953.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-5600&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-5600&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-5600&client=summon